Comet (COTN) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
17 Dec, 2025Executive summary
Revenue increased by 12.1% year-over-year, driven by a semiconductor market upswing and strong PCT division performance.
EBITDA margin improved to 13.6%, with net income more than doubling and free cash flow of CHF 41.4 million.
Major product launches included the Synertia Matchbox line and CA20 X-ray system fab version, supporting innovation and market expansion.
Expansion in Malaysia and strengthened presence in Asia enhanced scalability and future growth prospects.
Dividend per share increased by 50% to CHF 1.50, supported by strong free cash flow.
Financial highlights
Net sales reached CHF 445.4 million (+12.1% vs. FY23), with EBITDA CHF 60.4 million (+34.2%) and net income CHF 35.1 million (+128.2%).
Gross margin improved to 43.4% (from 41.0%), and ROCE increased to 10.4% (from 6.6%).
Free cash flow yield reached 9.2%, nearing the midterm target of 10-15%.
Cash and cash equivalents rose 31.2% to CHF 113.7 million; net debt shifted to net cash of CHF -16.1 million.
EPS more than doubled to CHF 4.52; dividend payout ratio at 33%.
Outlook and guidance
FY25 revenue guidance: CHF 480–520 million; EBITDA margin: 17.0–20.0%.
Cautiously optimistic outlook for 2025, with semiconductor demand driven by AI, leading-edge logic, and DRAM.
Fab equipment spending projected to grow 0-5% to $100-116 billion.
Anticipated stronger second half of 2025, with all divisions expected to contribute to growth.
Continued investments in R&D, sales, and marketing to drive new product commercialization and Malaysia expansion.
Latest events from Comet
- Sales up 2.6% with strong 2026 outlook as semiconductor demand and margins set to rise.COTN
H2 20256 Mar 2026 - Net profit more than doubled as semiconductor recovery drove higher orders in H1 2024.COTN
H1 20242 Feb 2026 - Strong sales growth led by PCT, but margin pressure and cautious FY25 outlook persist.COTN
H1 202516 Nov 2025 - RF and x-ray innovation, AI, and Asian expansion target CHF 670–770M sales by 2028.COTN
CMD 202513 Nov 2025 - Q3 sales fell 9.4% year-over-year, but full-year guidance remains, with recovery seen in 2026.COTN
Q3 2025 TU17 Oct 2025